139 related articles for article (PubMed ID: 19157739)
1. Quantitative contrast enhanced ultrasound of the liver for time intensity curves-Reliability and potential sources of errors.
Ignee A; Jedrejczyk M; Schuessler G; Jakubowski W; Dietrich CF
Eur J Radiol; 2010 Jan; 73(1):153-8. PubMed ID: 19157739
[TBL] [Abstract][Full Text] [Related]
2. Intrahepatic transit time predicts liver fibrosis in patients with chronic hepatitis B: quantitative assessment with contrast-enhanced ultrasonography.
Li N; Ding H; Fan P; Lin X; Xu C; Wang W; Xu Z; Wang J
Ultrasound Med Biol; 2010 Jul; 36(7):1066-75. PubMed ID: 20620694
[TBL] [Abstract][Full Text] [Related]
3. Time-intensity-based quantification of vascularity with single-level dynamic contrast-enhanced ultrasonography: a pilot animal study.
Li J; Dong BW; Yu XL; Wang XH; Li CF
J Ultrasound Med; 2005 Jul; 24(7):975-83. PubMed ID: 15972712
[TBL] [Abstract][Full Text] [Related]
4. Hepatic perfusion parameters of contrast-enhanced ultrasonography correlate with the severity of chronic liver disease.
Liu D; Qian L; Wang J; Hu X; Qiu L
Ultrasound Med Biol; 2014 Nov; 40(11):2556-63. PubMed ID: 25218453
[TBL] [Abstract][Full Text] [Related]
5. In vitro evaluation of the impact of ultrasound scanner settings and contrast bolus volume on time-intensity curves.
Gauthier TP; Chebil M; Peronneau P; Lassau N
Ultrasonics; 2012 Jan; 52(1):12-9. PubMed ID: 21722933
[TBL] [Abstract][Full Text] [Related]
6. A practical approach for quantitative estimates of voxel-by-voxel liver perfusion using DCE imaging and a compartmental model.
Cao Y; Alspaugh J; Shen Z; Balter JM; Lawrence TS; Ten Haken RK
Med Phys; 2006 Aug; 33(8):3057-62. PubMed ID: 16964883
[TBL] [Abstract][Full Text] [Related]
7. Characterization of focal liver lesions by means of assessment of hepatic transit time with contrast-enhanced US.
Zhou X; Liu JB; Luo Y; Yan F; Peng Y; Lin L; Zhuang H
Radiology; 2010 Aug; 256(2):648-55. PubMed ID: 20656845
[TBL] [Abstract][Full Text] [Related]
8. An EFSUMB introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for quantification of tumour perfusion.
Dietrich CF; Averkiou MA; Correas JM; Lassau N; Leen E; Piscaglia F
Ultraschall Med; 2012 Aug; 33(4):344-51. PubMed ID: 22843433
[TBL] [Abstract][Full Text] [Related]
9. Assessment of global liver blood flow with quantitative dynamic contrast-enhanced ultrasound.
Gauthier TP; Wasan HS; Muhammad A; Owen DR; Leen EL
J Ultrasound Med; 2011 Mar; 30(3):379-85. PubMed ID: 21357560
[TBL] [Abstract][Full Text] [Related]
10. Perfusion quantification using dynamic contrast-enhanced ultrasound: the impact of dynamic range and gain on time-intensity curves.
Gauthier TP; Averkiou MA; Leen EL
Ultrasonics; 2011 Jan; 51(1):102-6. PubMed ID: 20643467
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of Inflammatory from Fibrotic Ileal Strictures among Patients with Crohn's Disease through Analysis of Time-Intensity Curves Obtained after Microbubble Contrast Agent Injection.
Quaia E; Gennari AG; van Beek EJR
Ultrasound Med Biol; 2017 Jun; 43(6):1171-1178. PubMed ID: 28385471
[TBL] [Abstract][Full Text] [Related]
12. Reliability, repeatability, and reproducibility of pulmonary transit time assessment by contrast enhanced echocardiography.
Herold IH; Saporito S; Bouwman RA; Houthuizen P; van Assen HC; Mischi M; Korsten HH
Cardiovasc Ultrasound; 2016 Jan; 14():1. PubMed ID: 26729228
[TBL] [Abstract][Full Text] [Related]
13. [A comparative study of the hepatic transit time (HTT) of different ultrasound contrast agents in patients with liver metastases and healthy controls].
Haendl T; Strobel D; Neureiter D; Esser K; Frieser M; Hahn EG; Bernatik T
Ultraschall Med; 2010 Dec; 31(6):582-8. PubMed ID: 20183780
[TBL] [Abstract][Full Text] [Related]
14. Gray scale contrast enhancement and quantification in different positions of rabbit liver.
Li J; Dong BW; Yu XL; Li CF
J Ultrasound Med; 2006 Jan; 25(1):7-14. PubMed ID: 16371550
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced ultrasonography for the evaluation of liver fibrosis after biliary obstruction.
Shin HJ; Chang EY; Lee HS; Hong JH; Park G; Kim HG; Kim MJ; Lee MJ
World J Gastroenterol; 2015 Mar; 21(9):2614-21. PubMed ID: 25759528
[TBL] [Abstract][Full Text] [Related]
16. Liver Function Assessment Using Parenchyma-Specific Contrast-Enhanced Ultrasonography.
Park J; Cho J; Kwon H; Kang M; Lee S; Roh YH; Kim KW; Lee SW
Ultrasound Med Biol; 2016 Feb; 42(2):430-7. PubMed ID: 26610713
[TBL] [Abstract][Full Text] [Related]
17. Ultrasonic microbubble contrast agents and the transplant kidney.
Kay DH; Mazonakis M; Geddes C; Baxter G
Clin Radiol; 2009 Nov; 64(11):1081-7. PubMed ID: 19822241
[TBL] [Abstract][Full Text] [Related]
18. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
19. Quantitative evaluation of microvascular blood flow by contrast-enhanced ultrasound (CEUS).
Greis C
Clin Hemorheol Microcirc; 2011; 49(1-4):137-49. PubMed ID: 22214685
[TBL] [Abstract][Full Text] [Related]
20. Dynamic contrast-enhanced ultrasound and transient arterial occlusion for quantification of arterial perfusion reserve in peripheral arterial disease.
Amarteifio E; Wormsbecher S; Krix M; Demirel S; Braun S; Delorme S; Böckler D; Kauczor HU; Weber MA
Eur J Radiol; 2012 Nov; 81(11):3332-8. PubMed ID: 22285606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
